SEARCH · Engineering Papers
Results for “ECS”
Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Influence of regional nighttime atmospheric regimes on canopy turbulence and gradients at a closed and open forest in mountain-valley terrain
Stable stratification of the nocturnal lower boundary layer inhibits convective turbulence, such that turbulent vertical transfer of ecosystem carbon dioxide (CO 2 ), water vapor (H 2 O) and energy is driven by mechanically forced turbulence, either from frictional forces near the ground or top of a plant canopy, or from shear generated aloft. The significance of this last source of turbulence on canopy flow characteristics in a closed and open forest canopy is addressed in this paper. We present micrometeorological observations of the lower boundary layer and canopy air space collected on nearly 200 nights using a combination of atmospheric laser detection and ranging (lidar), eddy covariance (EC), and tower profiling instrumentation. Two AmeriFlux/Fluxnet sites in mountain-valley terrain in the Western U.S. are investigated: Wind River, a tall, dense conifer canopy, and Tonzi Ranch, a short, open oak canopy. On roughly 40% of nights lidar detected down-valley or downslope flows above the canopy at both sites. Nights with intermittent strong bursts of “top-down” forced turbulence were also observed above both canopies. The strongest of these bursts increased sub-canopy turbulence and reduced canopy virtual potential temperature (θv) gradient at Tonzi, but did not appear to change the flow characteristics within the dense Wind River canopy. At Tonzi we observed other times when high turbulence (via friction velocity, u*) was found just above the trees, yet CO2 and θv gradients remained large and suggested flow decoupling. These events were triggered by regional downslope flow. Lastly, a set of turbulence parameters is evaluated for estimating canopy turbulence mixing strength. The relationship between turbulence parameters and canopy θv gradients was found to be complex, although better agreement between the canopy θv gradient and turbulence was found for parameters based on the standard deviation of vertical velocity, or ratios of 3-D turbulence to mean flow, than for u*. These findings add evidence that the relationship between canopy turbulence, static stability, and canopy mixing is far from straightforward even within an open canopy.
Combining eddy-covariance and chamber measurements to determine the methane budget from a small, heterogeneous urban floodplain wetland park
Methane (CH 4 ) emissions and carbon uptake in temperate freshwater wetlands act in opposing directions in the context of global radiative forcing. Large uncertainties exist for the rates of CH 4 emissions making it difficult to determine the extent that CH 4 emissions counteract the carbon sequestration of wetlands. Urban temperate wetlands are typically small and feature highly heterogeneous land cover, posing an additional challenge to determining their CH 4 budget. The data analysis approach we introduce here combines two different CH 4 flux measurement techniques to overcome scale and heterogeneity problems and determine the overall CH 4 budget of a small, heterogeneous, urban wetland landscape. Temporally intermittent point measurements from non-steady-state chambers provided information about patch-level heterogeneity of fluxes, while continuous, high temporal resolution flux measurements using the eddy-covariance (EC) technique provided information about the temporal dynamics of the fluxes. Patch-level scaling parameterization was developed from the chamber data to scale eddy covariance data to a ‘fixed-frame’, which corrects for variability in the spatial coverage of the eddy covariance observation footprint at any single point in time. Finally, by combining two measurement techniques at different scales, we addressed shortcomings of both techniques with respect to heterogeneous wetland sites.
Aboveground and belowground contributions to ecosystem respiration in a temperate deciduous forest
In this study, we developed a three-way carbon dioxide (CO 2 ) flux-partitioning algorithm that separates net ecosystem exchange (NEE) into aboveground plant respiration (R above ), belowground root and soil respiration (R below ), and gross primary production (GPP). We applied this algorithm to a coupled dataset of continuous chamber-measured soil respiration and eddy covariance (EC)-measured NEE of CO 2 in an oak-hickory (Quercus-Carya) deciduous broadleaf forest from 2006 to 2015. We found that on annual time scale, R below dominated over R above with the former accounting for 66.9–86.4% and the latter 13.6–33.1%, of the total ecosystem respiration (R eco ). The ratio of R below to R above varied seasonally, ranging from 1.77 to 7.25 in growing season, and 1.02 to 4.57 in non-growing season. The temperature sensitivity (E 0 ) of R below was significantly higher than that of R above , and E 0 of R eco responded differently to air and soil temperature. Over the whole study period, annual mean R above , R below , and GPP were 243, 806, and 1170 g C m –2 , respectively, with annual R eco accounting for 89.6% of GPP, of which 68.8% was lost as R below and 20.8% lost as R above , and leaving only 10% of the carbon fixation in ecosystems. Furthermore, these estimates, however, did not consider potential light inhibition of leaf respiration. If we accept the presence of light inhibition, then the daytime three-way partitioning method would underestimate annual R above by 20.4% whereas the nighttime method would overestimate R above by 23.9% and GPP by 4.7%, compared with estimates accounting for light inhibition in leaves.
Can magnetogenesis driven by dynamo instabilities in chiral fermion plasmas, favor Einstein–Cartan AdS cosmology?
In this letter we show that the magnetic field (MF) bounds induced by Einstein–Cartan–de Sitter (EC) with AdS anti-de Sitter spacetime geometry and fermionic torsion with chiral dynamo plasmas instabilities, with inhomogeneous uniform chiral chemical potential, indicates that there is a possibility, as far as magnetogenesis is concerned, that we may obtain more stringent results within ECAdS gravity, compared with general relativity (GR) limits obtained by Tsagas using torsionless magnetogenesis. Spinorial fermionic source with torsion induces a chiral plasmas oscillation. The time dependent chiral chemical potential, sometimes associated formally with torsion, (de Andrade, 2018), is obtained from chiral flipping equation. The MFs obtained from the present universe ECdS chiral dynamo model, meet the criteria of galactic seed fields with better limits within Tsagas range (Tsagas, 2015) seed galactic magnetic fields for dynamo mechanisms, than the bound obtained by chiral dynamos in torsionless AdS cosmology. Majorana neutrinos are used as spatial components of axial spin-torsion source of dynamo instability from neutrino asymmetry.
Optimizing Distributed Energy Resources and building retrofits with the strategic DER-CAModel
The pressuring need to reduce the import of fossil fuels as well as the need to dramatically reduce CO 2 emissions in Europe motivated the European Commission (EC) to implement several regulations directed to building owners. Most of these regulations focus on increasing the number of energy efficient buildings, both new and retrofitted, since retrofits play an important role in energy efficiency. Overall, this initiative results from the realization that buildings will have a significant impact in fulfilling the 20/20/20-goals of reducing the greenhouse gas emissions by 20%, increasing energy efficiency by 20%, and increasing the share of renewables to 20%, all by 2020. The Distributed Energy Resources Customer Adoption Model (DER-CAM) is an optimization tool used to support DER investment decisions, typically by minimizing total annual costs or CO 2 emissions while providing energy services to a given building or microgrid site. This document shows enhancements made to DER-CAM to consider building retrofit measures along with DER investment options. Specifically, building shell improvement options have been added to DER-CAM as alternative or complementary options to investments in other DER such as PV, solar thermal, combined heat and power, or energy storage. The extension of the mathematical formulation required by the new features introduced in DER-CAM is presented and the resulting model is demonstrated at an Austrian Campus building by comparing DER-CAM results with and without building shell improvement options. Strategic investment results are presented and compared to the observed investment decision at the test site. Results obtained considering building shell improvement options suggest an optimal weighted average U value of about 0.53 W/(m 2 K) for the test site. This result is approximately 25% higher than what is currently observed in the building, suggesting that the retrofits made in 2002 were not optimal. Furthermore, the results obtained with DER-CAM illustrate the complexity of interactions between DER and passive measure options, showcasing the need for a holistic optimization approach to effectively optimize energy costs and CO 2 emissions. Lastly, the simultaneous optimization of building shell improvements and DER investments enables building owners to take one step further towards nearly zero energy buildings (nZEB) or nearly zero carbon emission buildings (nZCEB), and therefore support the 20/20/20 goals.
A worldwide aerosol phenomenology: Elemental and organic carbon in PM 2.5 and PM 10
Elemental carbon (EC), organic carbon (OC), and particulate matter (PM) concentrations in the inhalable (PM 10 ) and fine (PM 2.5 ) size fractions are measured worldwide, albeit with different analytical methods. These measurements from many researchers were collected and analyzed for Africa, America, Asia, and Europe for 2012–2019. EC/PM, OC/PM, and OC/EC ratios were examined based on region, site type, and season to infer potential sources and impacts. These analyses demonstrate that carbonaceous materials are important PM constituents throughout the world. Mean EC/PM ratios were lowest in PM 10 in Sahelian Africa and Europe (∼0.01), highest (>0.07) in PM 2.5 at urban sites in North America, South America, and Japan. Mean OC/PM ratios were lowest in PM 10 in the Sahel (∼0.06) and in PM 2.5 in China and Thailand (0.10), and highest in central and eastern Europe (∼0.3) and North America (∼0.4). OC/EC ratios were elevated in western and northern Europe, and at regional background sites in North America. EC/PM increased with PM 10 in Thailand, while OC/PM increased with higher PM mass in Thailand, India, and North America, highlighting the specific contribution of carbonaceous aerosols to PM pollution in these regions. At European and North American background sites, OC/EC ratios increased with PM mass. Higher OC/EC ratios in dry periods indicate influence of wildfires, prescribed burns, and secondary aerosol formation. Elevated wintertime EC/PM ratios coincide with residential heating in temperate climate zones.
Distinct physiological roles for the two L-asparaginase isozymes of Escherichia coli
Highlights: •Escherichia coli contains two L-asparaginase isozymes with distinct localization, kinetics and regulation. •Mutant strains were used to examine the roles of these enzymes in L-asparagine utilization. •We report that L-asparaginase II permits growth on asparagine and glycerol under anaerobic conditions. •We propose that this enzyme is the first step in a co-regulated pathway leading to fumarate. •The pathway is regulated by anaerobiosis and cAMP and provides a terminal elector acceptor. -- Abstract: Escherichia coli expresses two L-asparaginase (EC 3.5.1.1) isozymes: L-asparaginse I, which is a low affinity, cytoplasmic enzyme that is expressed constitutively, and L-asparaginase II, a high affinity periplasmic enzyme that is under complex co-transcriptional regulation by both Fnr and Crp. The distinct localisation and regulation of these enzymes suggest different roles. To define these roles, a set of isogenic mutants was constructed that lacked either or both enzymes. Evidence is provided that L-asparaginase II, in contrast to L-asparaginase I, can be used in the provision of an anaerobic electron acceptor when using a non-fermentable carbon source in the presence of excess nitrogen.
Pirfenidone enhances the efficacy of combined radiation and sunitinib therapy
Radiotherapy is a widely used treatment for many tumors. Combination therapy using anti-angiogenic agents and radiation has shown promise; however, these combined therapies are reported to have many limitations in clinical trials. Here, we show that radiation transformed tumor endothelial cells (ECs) to fibroblasts, resulting in reduced vascular endothelial growth factor (VEGF) response and increased Snail1, Twist1, Type I collagen, and transforming growth factor (TGF)-β release. Irradiation of radioresistant Lewis lung carcinoma (LLC) tumors greater than 250 mm{sup 3} increased collagen levels, particularly in large tumor vessels. Furthermore, concomitant sunitinib therapy did not show a significant difference in tumor inhibition versus radiation alone. Thus, we evaluated multimodal therapy that combined pirfenidone, an inhibitor of TGF-induced collagen production, with radiation and sunitinib treatment. This trimodal therapy significantly reduced tumor growth, as compared to radiation alone. Immunohistochemical analysis revealed that radiation-induced collagen deposition and tumor microvessel density were significantly reduced with trimodal therapy, as compared to radiation alone. These data suggest that combined therapy using pirfenidone may modulate the radiation-altered tumor microenvironment, thereby enhancing the efficacy of radiation therapy and concurrent chemotherapy. - Highlights: • Radiation changes tumor endothelial cells to fibroblasts. • Radio-resistant tumors contain collagen deposits, especially in tumor vessels. • Pirfenidone enhances the efficacy of combined radiation and sunitinib therapy. • Pirfenidone reduces radiation-induced collagen deposits in tumors.
Infantile hemangioma-derived stem cells and endothelial cells are inhibited by class 3 semaphorins
Class 3 semaphorins were discovered as a family of axon guidance molecules, but are now known to be involved in diverse biologic processes. In this study, we investigated the anti-angiogenic potential of SEMA3E and SEMA3F (SEMA3E&F) in infantile hemangioma (IH). IH is a common vascular tumor that involves both vasculogenesis and angiogenesis. Our lab has identified and isolated hemangioma stem cells (HemSC), glucose transporter 1 positive (GLUT1{sup +}) endothelial cells (designated as GLUT1{sup sel} cells) based on anti-GLUT1 magnetic beads selection and GLUT1-negative endothelial cells (named HemEC). We have shown that these types of cells play important roles in hemangiogenesis. We report here that SEMA3E inhibited HemEC migration and proliferation while SEMA3F was able to suppress the migration and proliferation in all three types of cells. Confocal microscopy showed that stress fibers in HemEC were reduced by SEMA3E&F and that stress fibers in HemSC were decreased by SEMA3F, which led to cytoskeletal collapse and loss of cell motility in both cell types. Additionally, SEMA3E&F were able to inhibit vascular endothelial growth factor (VEGF)-induced sprouts in all three types of cells. Further, SEMA3E&F reduced the level of p-VEGFR2 and its downstream p-ERK in HemEC. These results demonstrate that SEMA3E&F inhibit IH cell proliferation and suppress the angiogenic activities of migration and sprout formation. SEMA3E&F may have therapeutic potential to treat or prevent growth of highly proliferative IH. - Highlights: • SEMA3E&F reduce actin stress fibers and induce cytoskeletal collapse in HemEC. • SEMA3E&F inhibit angiogenic activities of HemEC. • SEMA3E&F can interrupt the VEGF-A-VEGFR2-ERK signaling pathway in HemEC. • Plexin D1 and NRP2 are induced during HemSC/GLUT1{sup sel}-to-EC differentiation.
Identification and characterization of a dipeptidyl peptidase IV inhibitor from aronia juice
Aronia berries have many potential effects on health, including an antioxidant effect, effect for antimutagenesis, hepatoprotection and cardioprotection, an antidiabetic effect and inhibition of cancer cell proliferation. Previous human studies have shown that aronia juice may be useful for treatment of obesity disorders. In this study, we found that aronia juice has an inhibitory effect against dipeptidyl peptidase IV (DPP IV) (EC 3.4.14.5). DPP IV is a peptidase that cleaves the N-terminal region of incretins such as glucagon-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). Inactivation of incretins by DPP IV induces reduction of insulin secretion. Furthermore, we identified that cyanidin 3, 5-diglucoside as the DPP IV inhibitor in aronia juice. DPP IV was inhibited more strongly by cyanidin 3, 5-diglucoside than by cyanidin and cyanidin 3-glucoside. The results suggest that DPP IV is inhibited by cyanidin 3, 5-diglucoside present in aronia juice. The antidiabetic effect of aronia juice may be mediated through DPP IV inhibition by cyanidin 3, 5-diglucoside. - Highlights: • DPP IV activity is inhibited by aronia juice. • DPP IV inhibitor is cyanidin 3, 5-diglucoside in aronia juice. • DPP IV is inhibited by cyanidin 3, 5-diglucoside more than cyanidin and cyanidin 3-glucoside.
Mefloquine effectively targets gastric cancer cells through phosphatase-dependent inhibition of PI3K/Akt/mTOR signaling pathway
Deregulation of PI3K/Akt/mTOR pathway has been recently identified to play a crucial role in the progress of human gastric cancer. In this study, we show that mefloquine, a FDA-approved anti-malarial drug, effectively targets human gastric cancer cells. Mefloquine potently inhibits proliferation and induces apoptosis of a panel of human gastric cancer cell lines, with EC{sub 50} ∼0.5–0.7 μM. In two independent gastric cancer xenograft mouse models, mefloquine significantly inhibits growth of both tumors. The combination of mefloquine with paclitaxel enhances the activity of either drug alone in in vitro and in vivo. In addition, mefloquine potently decreased phosphorylation of PI3K, Akt, mTOR and rS6. Overexpression of constitutively active Akt significantly restored mefloquine-mediated inhibition of mTOR phosphorylation and growth, and induction of apoptosis, suggesting that mefloquine acts on gastric cancer cells via suppressing PI3K/Akt/mTOR pathway. We further show that mefloquine-mediated inhibition of Akt/mTOR singaling is phosphatase-dependent as pretreatment with calyculin A does-dependently reversed mefloquine-mediated inhibition of Akt/mTOR phosphorylation. Since mefloquine is already available for clinic use, these results suggest that it is a useful addition to the treatment armamentarium for gastric cancer. - Highlights: • Mefloquine targets a panel of gastric cancer cell lines in vitro and in vivo. • Combination of mefloquine and paclitaxel is synergistic. • Mefloquine acts on gastric cancer via inhibition of PI3K/Akt/mTOR pathway. • Mefloquine can be repurposed for gastric cancer treatment.
Peripheral and central localization of the nesfatin-1 receptor using autoradiography in rats
Nesfatin-1 was recently identified and introduced as food intake-regulatory hormone. Soon thereafter, mounting evidence indicated a much broader role for nesfatin-1 with an involvement in the regulation of food intake, gastrointestinal motility, glucose homeostasis, blood pressure and stress. Despite the growing knowledge on the physiological regulation and functions of nesfatin-1, the receptor mediating these effects remains to be characterized. Therefore, the aim of this study was to investigate the peripheral and central localization of the nesfatin-1 receptor by autoradiography. Male Sprague–Dawley rats were used and peripheral as well as brain tissue was processed for {sup 125}I-nesfatin-1 autoradiography. In peripheral tissues, an autoradiographic signal was observed in the gastric mucosa of corpus and antrum, in duodenum, jejunum and ileum, while no signal was detected in the colon. Preabsorption of {sup 125}I-nesfatin-1 with non-labeled nesfatin-1 greatly diminished the autoradiographic signal in the stomach indicating specificity (−32%, p < 0.001). A displacement assay showed an effective concentration by which 50% of {sup 125}I-nesfatin-1 bound to the receptor (EC{sub 50}) in the gastric corpus of 80 pM. Moreover, autoradiography was observed in endocrine tissues including the pituitary, pancreas, adrenal gland, testis and visceral adipose tissue. In addition, also heart, skeletal muscle, lung, liver and kidney showed autoradiographic signals. In the brain, strong {sup 125}I-nesfatin-1 autoradiography was detected in the cortex, paraventricular nucleus of the hypothalamus, area postrema, dorsal motor nucleus of the vagus nerve and cerebellum. Based on the distribution of nesfatin-1 autoradiography, nesfatin-1 is a pleiotropic hormone that is involved in the regulation of several homeostatic functions. - Highlights: • Although our knowledge on nesfatin-1 is increasing, the receptor is still unknown. • {sup 125}I-nesfatin-1 autoradiography was detected in (a.o.) the stomach and pancreas. • Central signals were observed in the hypothalamic paraventricular and dorsal motor nucleus. • Distribution data support the notion of nesfatin-1 being a pleiotropic hormone.
Crystal structure of the kinase domain of human protein tyrosine kinase 6 (PTK6) at 2.33 Å resolution
Human Protein tyrosine kinase 6 (PTK6) (EC:2.7.10.2), also known as the breast tumor kinase (BRK), is an intracellular non-receptor Src-related tyrosine kinase expressed in a majority of human breast tumors and breast cancer cell lines, but its expression is low or completely absent in normal mammary glands. In the recent past, several studies have suggested that PTK6 is a potential therapeutic target in cancer. To understand its structural and functional properties, the PTK6 kinase domain (PTK6-KD) gene was cloned, overexpressed in a baculo-insect cell system, purified and crystallized at room temperature. X-ray diffraction data to 2.33 Å resolution was collected on a single PTK6-KD crystal, which belonged to the triclinic space group P1. The Matthews coefficient calculation suggested the presence of four protein molecules per asymmetric unit, with a solvent content of ∼50%.The structure has been solved by molecular replacement and crystal structure data submitted to the protein data bank under the accession number 5D7V. This is the first report of apo PTK6-KD structure crystallized in DFG-in and αC-helix-out conformation. - Highlights: • We report the first crystal structure of the kinase domain of human PTK6. • >95% pure recombinant protein was purified in two-steps protocol: affinity chromatography followed by gel filtration. • Kinase activity of the crystal construct is comparable to the full length enzyme. • This apo PTK6-KD is in DFG-in and αC-helix-out conformation.
Co-crystal structures of PTK6: With Dasatinib at 2.24 Å, with novel imidazo[1,2-a]pyrazin-8-amine derivative inhibitor at 1.70 Å resolution
Human Protein tyrosine kinase 6 (PTK6)(EC:2.7.10.2), also known as the breast tumor kinase (BRK), is an intracellular non-receptor Src-related tyrosine kinase expressed five-fold or more in human breast tumors and breast cancer cell lines but its expression being low or completely absent from normal mammary gland. There is a recent interest in targeting PTK6-positive breast cancer by developing small molecule inhibitor against PTK6. Novel imidazo[1,2-a]pyrazin-8-amines (IPA) derivative compounds and FDA approved drug, Dasatinib are reported to inhibit PTK6 kinase activity with IC{sub 50} in nM range. To understand binding mode of these compounds and key interactions that drive the potency against PTK6, one of the IPA compounds and Dasatinib were chosen to study through X-ray crystallography. The recombinant PTK6 kinase domain was purified and co-crystallized at room temperature by the sitting-drop vapor diffusion method, collected X-ray diffraction data at in-house and resolved co-crystal structure of PTK6-KD with Dasatinib at 2.24 Å and with IPA compound at 1.70 Å resolution. Both these structures are in DFG-in & αC-helix-out conformation with unambiguous electron density for Dasatinib or IPA compound bound at the ATP-binding pocket. Relative difference in potency between Dasatinib and IPA compound is delineated through the additional interactions derived from the occupation of additional pocket by Dasatinib at gatekeeper area. Refined crystallographic coordinates for the kinase domain of PTK6 in complex with IPA compound and Dasatinib have been submitted to Protein Data Bank under the accession number (5DA3) and (5H2U) respectively. - Highlights: • We report first co-crystal structures of human PTK6 with potent inhibitors bound at the ATP binding pocket. • Relative difference in potency between FDA approved drug, Dasatinib and an inhibitor is delineated at the molecular level. • These co-crystal structures of PTK6-KD are in DFG-in and αC-helix-out conformation.
Chlamydia pneumoniae infection promotes monocyte transendothelial migration by increasing vascular endothelial cell permeability via the tyrosine phosphorylation of VE-cadherin
Highlights: • C. pneumoniae infection promotes monocyte TEM through increasing VEC permeability. • C. pneumoniae infection stimulates VE-cadherin tyrosine phosphorylation by Src. • VE-cadherin phosphorylation is involved in VE-cadherin internalization. • VE-cadherin phosphorylation is involved in EC hyperpermeability caused by infection. • VE-cadherin phosphorylation is associated with the infection-induced monocyte TEM. Migration of monocytes into the subendothelial layer of the intima is one of the critical events in early atherosclerosis. Chlamydia pneumoniae (C. pneumoniae) infection has been shown to promote monocyte transendothelial migration (TEM). However, the exact mechanisms have not yet been fully clarified. In this study, we tested the hypothesis that C. pneumoniae infection increases vascular endothelial cell (VEC) permeability and subsequent monocyte TEM through stimulating the tyrosine phosphorylation of vascular endothelial-cadherin (VE-cadherin). Here, we demonstrated that C. pneumoniae infection promoted monocyte TEM in a TEM assay possibly by increasing the permeability of a VEC line EA.hy926 cell as assessed by measuring the passage of FITC-BSA across a VEC monolayer. Subsequently, Western blot analysis showed that C. pneumoniae infection induced VE-cadherin internalization. Our further data revealed that Src-mediated VE-cadherin phosphorylation at Tyr658 was involved in C. pneumoniae infection-induced internalization of VE-cadherin, VEC hyperpermeability and monocyte TEM. Taken together, our data indicate that C. pneumoniae infection promotes monocyte TEM by increasing VEC permeability via the tyrosine phosphorylation and internalization of VE-cadherin in VECs.
T2DM inhibition of endothelial miR-342-3p facilitates angiogenic dysfunction via repression of FGF11 signaling
Understanding the function and molecular relevance of distinct miRNAs in endothelial cells (ECs) paves avenues for possible therapeutic intervention by targeting epigenetic mechanisms in vascular endothelial dysfunction, one of the major complications of type 2 diabetes mellitus (T2DM). MiR-342-3p, an obesity-associated miRNA, has recently been shown to be significantly upregulated in human angiosarcoma compared to benign hemangioma, indicating its potential involvement as a proangiogenic factor. Herein, we show that endothelial miR-342-3p expression was significantly compromised in T2DM organisms and this inhibition powerfully blocked vasculogenesis in vivo by repressing endothelial proliferation and migration. From a mechanistic standpoint, miR-342-3p promoted the transactivation of fibroblast growth factor 11 (FGF11) by directly targeting its 3′ untranslated regions (3′UTRs). Functionally, overexpression of exogenous FGF11 successfully rescued miR-342-3p deficiency-impaired endothelial proliferation and migration. Thus, perturbation of miR-342-3p/FGF11 cascade by hyperinsulinemia plays a causative role in the induction of vascular dysfunction in T2DM. Overall, the current study underscore an endothelial facet of miR-342-3p, which may operate as a novel epigenetic integrator linking adipogenic homeostasis and angiogenesis.
E3317 promotes cholesterol efflux in macrophage cells via enhancing ABCA1 expression
Highlights: • E3317 was first found as an ABCA1 upregulator in an ABCA1 transcriptional activity assay. • E3317 increased ABCA1 mRNA and protein expression in both L02 and RAW264.7 cells. • E3317 promoted cholesterol efflux and reduced cellular lipid accumulation in RAW264.7 macrophages dependent on ABCA1. • E3317 upregulated ABCA1 expression through activating PPARγ. • Y327 and F363 are the key PPARγ binding epitopes of E3317. Reverse cholesterol transport (RCT) plays an important role in cholesterol and lipid metabolism. Regulating the activities of key transporters and receptors in RCT, such as ATP-binding cassette transporter A1 (ABCA1), helps to prevent atherosclerotic cardiovascular disease. In this study, we used an ABCA1 promoter luciferase reporter assay to screen 20,000 compounds for ABCA1 upregulators. Compound E3317 (N-(6-butylbenzo[d]thiazol-2(3H)-ylidene)-3-(N-(2-cyanoethyl)sulfamoyl)benzamide)) was identified as a positive hit with an EC{sub 50} value of 0.2 μM in ABCA1p-LUC HepG2 cells. Thus, we hypothesized that E3317 might have cholesterol- and lipid metabolism-regulating effects through ABCA1 upregulation. E3317 significantly increased ABCA1 mRNA and protein expression in hepatic L02 cells and RAW264.7 macrophages. E3317 promoted cholesterol efflux to apolipoprotein A-I in RAW264.7 macrophages and significantly decreased lipid accumulation in oxidized low-density lipoprotein-induced murine RAW264.7 macrophages. Further studies using ABCA1 siRNA showed that the promotion of cholesterol efflux and decrease of lipid accumulation by E3317 depended on ABCA1 expression. Mechanistic studies indicated that E3317 regulated ABCA1 expression via activating nuclear receptor peroxisome proliferator-activated receptor gamma (PPARγ), which plays an important role in the regulation of glucose homeostasis and lipid metabolism. The structure of E3317 was docked in the ligand-binding domain of PPARγ (PBD code: 4EMA) to find the key binding amino acids. Site mutation assays confirmed that Y327 and F363 were the key PPARγ binding epitopes of E3317. Our results revealed that E3317 upregulates ABCA1 expression and thereby promotes cholesterol efflux. E3317 may regulate ABCA1 expression through PPARγ. Our findings provide a new compound, E3317, which may have beneficial cardiovascular effects.